Company news
Lonza Group Ag (SIX:LONN) news
Every Lonza Group Ag press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Lonza Appoints Samanta Cimitan as Chief Commercial Officer
August 26, 2026
Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea
August 5, 2026
Lonza Delivered Strong H1 2026 Performance Across All Business Platforms and Upgrades Full-Year 2026 Margin Outlook
July 22, 2026
Lonza Publishes Restated Half-Year 2025 Financials Reflecting Capsules & Health Ingredients as Discontinued Operations
June 23, 2026
Lonza Issues Exclusive, Target-Specific License to Antharis Therapeutics to Advance Next-Generation Dual Payload ADCs for Gastrointestina...
June 15, 2026
Lonza Appoints Hans Trees as Global Head of Communications
June 9, 2026
Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved
May 8, 2026
Lonza Delivers Strong Performance in Q1 2026 in Line with Expectations and Confirms Full-Year Outlook 2026
May 8, 2026
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
April 21, 2026
Specialty Triglycerides Market Dominates Nutrition and Pharmaceutical Applications with Lonza, BASF, Stepan Company
April 1, 2026
Lonza Nominates Stephen Fry as Independent Board Member
March 31, 2026
Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO™
March 9, 2026
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG
March 6, 2026
Changes to the Composition of the Lonza Board
February 13, 2026
Lonza Delivers Strong Profitable Growth in Full-Year 2025 and Successfully Completes Vacaville Site Integration
January 28, 2026
Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific...
January 7, 2026
GBI Biomanufacturing Announces the Appointment of Jesse McCool, Ph.D. as President
January 6, 2026
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses
October 23, 2025
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member
October 3, 2025
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC
September 25, 2025
Lonza Appoints Jason Berndt as Head of Group Operations, and Maria Soler Nunez as Chief Quality Officer
September 12, 2025
Lonza Delivers Strong H1 2025 Performance and Upgrades 2025 Full-Year CDMO Sales and Margin Outlook
July 23, 2025
Lonza Publishes 2024 Comparative Financials Under One Lonza Organizational Structure
May 27, 2025
Lonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer
May 15, 2025
Lonza Announces Results of the 2025 Annual General Meeting – All Motions Proposed by Board of Directors Approved
May 9, 2025
Lonza Q1 2025 Qualitative Update: Strong Performance Across All Businesses in Line with Expectations for Full-Year 2025
May 9, 2025
Lonza Publishes Invitation to the 2025 Annual General Meeting and 2024 Annual and Sustainability Reports
April 3, 2025